Verily’s Amy Abernethy hints at clinical trial blueprint for 2022
Amy Abernethy, president of Verily’s clinical trials platform, laid out the pillars of the company's strategy in 2022.
Read The StoryHealth Tech
Tracking how tech is transforming health care and the life sciences. To get the latest delivered to your inbox, sign up for our free STAT Health Tech newsletter. And subscribe to STAT+ for exclusive analysis of the interlopers and technologies disrupting health care.
Telehealth for PTSD, SPAC sadness, & FDA clears VR
A telehealth effort to treat PTSD and bipolar disorder in rural areas showed ‘huge gains.’ Now comes the hard part
‘It’s going to set the bar pretty high’: A path forward for trusted AI in breast cancer risk prediction
5 health tech startups targeting the Medicaid population to watch
All Coverage
advertisement
